Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We just wait...... that is what we do !!

IMO, you are very very right. This is not a dead company with no hope. However, it is also not a high flyer with tons of upside if one were to look only at the past Q reports and license announcements with the cooresponding effect on our pps. We have to look further and there are many differing opines.

Expectations, mine included, were just too high for the last Q report. I believe we have seen all the J2.5 cash and we are moving on. I know there are other opinions, but it is easiest for me to just look at what I know PTSC is up to -- not what I once hoped for. If I am shocked by surprise earnings, great! Better than a Starbucks double shot.

Around the pre Q report time, I believed the speculation (mine included) and poured more money into PTSC. I'm sure many others did the same. Time will tell if we made good decisions. This is a speculative penny stock with no debt, tons-o-cash, and an ongoing unsteady and unknown revenue stream. If we could take out the "unsteady and unknown" what would today's pps be? (retorical, no WAGs please)

Keeping expectations in the reasonable range -- as ease stated makes sense to me -- will be much easier (no pun intended) than the WAG I thought would happen weeks ago.

With a positive USPTO ruling and further progress on the M & A front, PTSC can be what many of us believed it could be in the near future. Of course, defining "near future" is the problem. Few stocks work on my time line, but some do work out in the end. IMO, PTSC has as good a shot as any.

John

Share
New Message
Please login to post a reply